Clinical Oncology
Volume 20, Issue 7 , Pages 506-512 , September 2008

Palliative Radiotherapy for Women with Breast Cancer

  • B. Danielson

      Affiliations

    • Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
    • Corresponding Author InformationAuthor for correspondence: B. Danielson, Department of Radiation Oncology, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada. Tel: +780 432 8754; Fax: +780 432 8380.
  • ,
  • M. Winget

      Affiliations

    • Department of Population Health and Information, Cross Cancer Institute, Edmonton, Alberta, Canada
  • ,
  • Z. Gao

      Affiliations

    • Department of Population Health and Information, Cross Cancer Institute, Edmonton, Alberta, Canada
  • ,
  • B. Murray

      Affiliations

    • Department of Medical Physics, Cross Cancer Institute, Edmonton, Alberta, Canada
  • ,
  • R. Pearcey

      Affiliations

    • Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada

Received 28 September 2007 ,Revised 18 February 2008 ,Accepted 2 April 2008.

References 

  1. Canadian Cancer Statistics. www.cancer.ca2007;
  2. Gluck S. The prevention and management of distant metastases in women with breast cancer. Cancer Invest. 2007;25:6–13
  3. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55(3):565–567
  4. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol. 2005;6(1):15–24
  5. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev. 2006;19(3):CD003869
  6. Amichetti M, Caffo O, Minatel E, et al. Ocular metastases from breast carcinoma: a multicentric retrospective study. Oncol Rep. 2000;7(4):761–765
  7. Huang J, Zhou S, Groome P, Tyldesley S, Zhang-Salomons J, Mackillop WJ. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001;19(1):137–144
  8. Johnston GM, Boyd CJ, Joseph P, MacIntyre M. Variation in delivery of palliative radiotherapy to persons dying of cancer in Nova Scotia, 1994 to 1998. J Clin Oncol. 2001;19(14):3323–3332
  9. http://www.health.gov.ab.ca/regions/a-meth.htm
  10. http://www.yellowpages.ca/map/createdrivingdir.html?src=ypca
  11. http://support.sas.com/documentation/cdl/en/statug/59654/PDF/default/statug.pdf. pp 1892–2070.
  12. Townsley C, Pond GR, Peloza B, et al. Analysis of treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol. 2005;23(16):3802–3810
  13. Tyldesley S, Zhang-Salomons J, Groome PA, et al. Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 2000;47(2):469–480
  14. Mitsuhhashi N, Hayakawa K, Yamakawa M, et al. Cancer in patients aged 90 years old and older: radiation therapy. Radiology. 1999;211:829–833
  15. Ausili-Cefaro G, Olmi P. The role of radiotherapy in the management of elderly cancer patients in light of the GROG experience. Crit Rev Oncol Hematol. 2001;29:313–317
  16. Zacharia B, Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin North Am. 2000;14:131–167
  17. Paszat LF, Mackillop WJ, Groome PA, Zhang-Salomons J, Schulze K, Holowaty E. Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med. 1998;21(3):125–134
  18. Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys. 2002;53(5):1240–1253

PII: S0936-6555(08)00245-8

doi: 10.1016/j.clon.2008.04.013

Clinical Oncology
Volume 20, Issue 7 , Pages 506-512 , September 2008